Overview:

The global oral solid dosage pharmaceutical market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. Oral solid dosage form is highly preferred by the manufactures due to its convenience and safe way of administration. In addition, drugs with oral solid form are easy to manufacture and transport as they are chemically stable.

Market Dynamics:

Pharmaceutical sector across the globe is witnessing rapid development. Developing regulatory scenario and increasing investment for R&D activities are major factors expected to drive the growth of global oral solid dosage pharmaceutical market. In addition, changing lifestyle pattern and increasing number of patients suffering from lifestyle associated diseases is resulting in introduction of innovative solution in order to treat diseases, which is another factor expected to support the growth of target market.

High government spending on development of healthcare infrastructure along with increasing public-private partnerships for R&D activities are factors expected to fuel growth of the target market.

However, factors such as increasing research on biologics molecules and emergence of small enterprises with low cost innovative solutions are factors expected to hamper the growth of global oral solid dosage pharmaceutical market.

Key Trends:

Business development activities by major players through acquisitions and partnerships are key trend observed in the target market. In 2020, Piramal Pharma Solutions Inc. a contract development and manufacturing organization acquired solid oral dosage drug product manufacturing facility of G&W Laboratories Inc. This acquisition is expected to help the company to enhance the product portfolio and increase the revenue share.

Regional Analysis:

For detailed understanding of market dynamics, the global oral solid dosage pharmaceutical market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America accounted for the major revenue share in 2018, owing to rising number of patients suffering from various chronic diseases. In addition, high government spending on development of healthcare sector and increasing R&D activities by major players are factors expected to boost growth of the target market.

Major players are focused on enhancing the business presence and increasing the customer base through strategic merger and acquisition is expected to fuel growth of the global market.

Scope of the Report:

Detailed Segmentation:

Global Oral Solid Dosage Pharmaceutical Market, By Dosage Form:

• Tablets
• Capsules
• Powders

Global Oral Solid Dosage Pharmaceutical Market, By Type:

• Immediate Release
• Extended Release

Global Oral Solid Dosage Pharmaceutical Market, By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Drug Stores
• Online Pharmacy

Key Players Covered:

Key players operating in the market includes, AstraZeneca PLC, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Inc, Merck & Co., Inc., Novartis International AG, Pfizer Inc., AbbVie, and Boehringer Ingelheim.

Key Features of the Study:

Foresight Market Research provides detailed analysis on global market in our report- Global Oral Solid Dosage Pharmaceutical Market by dosage form, type, distribution channel, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global oral solid dosage pharmaceutical market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, market expansion, and marketing tactics used overall the globe.